CinCor Pharma Inc (CINC)
Stock chart
Earnings
Value bought
Past 90 days
Value sold
Past 90 days
Net insiders buying
Past 90 days
Trades (buy and sell)
Past 90 days
Search
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2023-02-27 | 2022-11-28 | S Sale | Non-Executive Director Large shareholder |
6,000
-100.0%
14.32USD 85,920 |
6,000 -100.0% | 14.32 | USD 85,920 | |
| 2022-08-17 | 2022-08-15 | B Purchase | Large shareholder |
487,333
+inf%
30.00USD 14,619,990 |
487,333 +inf% | 30.00 | USD 14,619,990 | |
| 2022-08-17 | 2022-08-15 | B Purchase | Large shareholder |
112,667
+2.9%
30.00USD 3,380,010 |
112,667 +2.9% | 30.00 | USD 3,380,010 | |
| 2022-08-17 | 2022-08-15 | B Purchase | Large shareholder |
133,333
+3.3%
30.00USD 3,999,990 |
133,333 +3.3% | 30.00 | USD 3,999,990 | |
| 2022-08-15 | 2022-08-11 | B Purchase |
GENERAL ATLANTIC GENPAR (BERMUDA), L.P. Large shareholder |
83,000
+2.0%
30.00USD 2,490,000 |
83,000 +2.0% | 30.00 | USD 2,490,000 | |
| 2022-08-15 | 2022-08-11 | B Purchase |
Sofinnova Venture Partners X, L.P. Large shareholder |
500,000
+9.0%
30.00USD 15,000,000 |
500,000 +9.0% | 30.00 | USD 15,000,000 | |
| 2022-08-15 | 2022-08-11 | B Purchase | Large shareholder |
83,000
+2.0%
30.00USD 2,490,000 |
83,000 +2.0% | 30.00 | USD 2,490,000 | |
| 2022-08-15 | 2022-08-11 | B Purchase | Non-Executive Director Large shareholder |
6,000
+inf%
30.00USD 180,000 |
6,000 +inf% | 30.00 | USD 180,000 | |
| 2022-08-15 | 2022-08-11 | B Purchase | Non-Executive Director Large shareholder |
500,000
+9.0%
30.00USD 15,000,000 |
500,000 +9.0% | 30.00 | USD 15,000,000 | |
| 2023-02-27 | 2022-06-10 | S Sale |
Chief Medical Officer Officer |
6
-0.2%
15.21USD 91 |
6 -0.2% | 15.21 | USD 91 | |
| 2022-01-13 | 2022-01-11 | B Purchase |
EVP CFO & Chief BD Officer Officer |
100
+inf%
16.00USD 1,600 |
100 +inf% | 16.00 | USD 1,600 | |
| 2022-01-13 | 2022-01-11 | B Purchase |
Sofinnova Venture Partners X, L.P. Large shareholder |
325,000
+6.2%
16.00USD 5,200,000 |
325,000 +6.2% | 16.00 | USD 5,200,000 | |
| 2022-01-13 | 2022-01-11 | B Purchase | Non-Executive Director Large shareholder |
325,000
+6.2%
16.00USD 5,200,000 |
325,000 +6.2% | 16.00 | USD 5,200,000 | |
| 2022-01-13 | 2022-01-11 | B Purchase | Large shareholder |
220,000
+5.7%
16.00USD 3,520,000 |
220,000 +5.7% | 16.00 | USD 3,520,000 | |
| 2022-01-13 | 2022-01-11 | B Purchase | Large shareholder |
312,500
+170.0%
16.00USD 5,000,000 |
312,500 +170.0% | 16.00 | USD 5,000,000 | |
| 2022-01-13 | 2022-01-11 | B Purchase | Large shareholder |
157,500
+4.3%
16.00USD 2,520,000 |
157,500 +4.3% | 16.00 | USD 2,520,000 | |
| 2022-01-13 | 2022-01-11 | B Purchase |
GENERAL ATLANTIC GENPAR (BERMUDA), L.P. Large shareholder |
1,700,000
+70.1%
16.00USD 27,200,000 |
1,700,000 +70.1% | 16.00 | USD 27,200,000 | |
| 2022-01-13 | 2022-01-11 | B Purchase |
Chief Executive Officer Executive Director |
12,500
+inf%
16.00USD 200,000 |
12,500 +inf% | 16.00 | USD 200,000 | |
| 2022-01-13 | 2022-01-11 | B Purchase |
Chief Operating Officer Officer |
1,500
+inf%
16.00USD 24,000 |
1,500 +inf% | 16.00 | USD 24,000 | |
| 2022-01-13 | 2022-01-11 | B Purchase |
Chief Operating Officer Officer |
750
+0.6%
16.00USD 12,000 |
750 +0.6% | 16.00 | USD 12,000 | |
| 2022-01-13 | 2022-01-11 | B Purchase |
EVP Clinical Development Officer |
100
+inf%
16.00USD 1,600 |
100 +inf% | 16.00 | USD 1,600 | |
| 2022-01-13 | 2022-01-11 | B Purchase |
EVP Clinical Development Officer |
2,500
+inf%
16.00USD 40,000 |
2,500 +inf% | 16.00 | USD 40,000 | |
| 2022-01-13 | 2022-01-11 | B Purchase | Large shareholder |
1,700,000
+70.1%
16.00USD 27,200,000 |
1,700,000 +70.1% | 16.00 | USD 27,200,000 |